With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Circulating tumor HPV-16 once again proves significantly predictive of cancer progression and survival, this time (LBA5) following surgery and/or radiation for HPV-related oropharyngeal cancer. | Routman, ASTRO 2019